Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lexaria Bioscience (LEXX) Asset Utilization Ratio (2017 - 2026)

Lexaria Bioscience's Asset Utilization Ratio history spans 10 years, with the latest figure at 0.06 for Q1 2026.

  • Quarterly results put Asset Utilization Ratio at 0.06 for Q1 2026, up 3.08% from a year ago — trailing twelve months through Feb 2026 was 0.06 (up 3.08% YoY), and the annual figure for FY2025 was 0.11, up 39.33%.
  • Asset Utilization Ratio for Q1 2026 was 0.06 at Lexaria Bioscience, down from 0.1 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 5.79 in Q1 2024 to a low of 0.02 in Q3 2022.
  • The 5-year median for Asset Utilization Ratio is 0.11 (2023), against an average of 0.74.
  • The sharpest move saw Asset Utilization Ratio surged 4156.13% in 2024, then plummeted 99.02% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.06 in 2022, then surged by 204.5% to 0.18 in 2023, then crashed by 69.92% to 0.05 in 2024, then soared by 91.7% to 0.1 in 2025, then plummeted by 42.5% to 0.06 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.06, 0.1, and 0.13 for Q1 2026, Q4 2025, and Q3 2025 respectively.